Related Experiment Video
Updated: May 22, 2026

Use of High-Throughput Automated Microbioreactor System for Production of Model IgG1 in CHO Cells
Published on: September 28, 2018
Development of a scaled-down aerobic fermentation model for scale-up in recombinant protein vaccine manufacturing
Patrick Farrell1, Jacob Sun, Meg Gao
1Bioprocess Research and Development, Sanofi Pasteur, Toronto, Canada M2R 3T4. patrick.farrell@sanofipasteur.com
Abstract:
A simple approach to the development of an aerobic scaled-down fermentation model is presented to obtain more consistent process performance during the scale-up of recombinant protein manufacture. Using a constant volumetric oxygen mass transfer coefficient (k(L)a) for the criterion of a scale-down process, the scaled-down model can be "tuned" to match the k(L)a of any larger-scale target by varying the impeller rotational speed. This approach is demonstrated for a protein vaccine candidate expressed in recombinant Escherichia coli, where process performance is shown to be consistent among 2-L, 20-L, and 200-L scales. An empirical correlation for k(L)a has also been employed to extrapolate to larger manufacturing scales.
More Related Videos
12:53Cell-Free Scaled Production and Adjuvant Addition to a Recombinant Major Outer Membrane Protein from Chlamydia muridarum for Vaccine Development
Published on: March 16, 2022
06:08Design of Solid-State Fermentation Systems for Polymer Hydrolytic Extracellular Enzyme Production by Filamentous Fungi
Published on: June 6, 2025
Related Concept Videos
Scale-Up Processes
Upstream Processing
Vaccine Production
Bioreactor Controls-III
Bioreactor Design and Operational System
Designing Growth Media for Bioreactors